Epstein-Barr Virus (EBV) and Low Dose Naltrexone (LDN)

Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Answered by LDN Specialist Pharmacist Dr Sam Lebsock
LDN Specialist Pharmacist Dr Sam Lebsock

Epstein-Barr Virus (EBV) and Low Dose Naltrexone (LDN)

A patient had mono over 20 years ago. She has high Epstein-Barr virus titer and is still high. She has chronic fatigue syndrome and she's wondering if LDN can help in lowering these antibodies levels, and if it can potentially help ease her chronic fatigue symptoms.

Yes. The use of Low Dose Naltrexone (LDN) with chronic fatigue syndrome has been documented pretty well. I think it's all over the LDN Research Trust website, so yes, this is a very good treatment option for these type of patients.

Will it help lower your antibodies? Yes. There's probably a little bit more to your story. I think I would need to know about your Epstein-Barr titer, and so we might have to take that offline a little bit, because there could be some underlying other things going on there that I think we might need to understand. But as far as antibodies decreasing, yes Low Dose Naltrexone (LDN) will help with that. And with chronic fatigue, it's been shown to have great great results there

Answered by Sam Lebsock, PharmD
LDN Specialist

For further Q&A's visit https://ldnresearchtrust.org/questions-and-answers